Results 1 to 10 of about 929,596 (350)

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study [PDF]

open access: goldRadiation Oncology, 2021
Background The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In this study, we aimed to verify the
Ting-Shi Su   +9 more
doaj   +8 more sources

Conventional versus different hypofractionated radiotherapy dosage schedules in postmastectomy advanced breast cancer [PDF]

open access: diamondJournal of Medical Physics, 2022
Introduction: The standard treatment for advanced breast cancer is surgery consisting of breast-conserving surgery or modified radical mastectomy (MRM) postneoadjuvant chemotherapy followed by adjuvant radiation treatment (RT).
Neeraj Jain   +4 more
doaj   +5 more sources

Optimal Stereotactic Body Radiotherapy Dosage For Hepatocellular Carcinoma [PDF]

open access: gold, 2020
AbstractBackground and purposeThe optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. We compared the effectiveness of stereotactic body radiation therapy dosing regimens for hepatocellular carcinoma (HCC)
Ting‐Shi Su   +6 more
semanticscholar   +3 more sources

Estimation of Biological Dosage Factors in Clinical Radiotherapy [PDF]

open access: bronzeBritish Journal of Cancer, 1951
IN a previous paper the writer (Cohen, 1949) proposed a biological dosage unit, the "roentgen equivalent clinical" (rec) based on an empirical formula D = E.a.Tn.L-q, relating the physical dose in roentgens (D) to the biological dose in rec (E), taking ...
Lionel Cohen
semanticscholar   +4 more sources

Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions

open access: yesFrontiers in Immunology, 2023
Esophageal squamous cell carcinoma (ESCC) is a common malignancy worldwide and often diagnosed at advanced stages with poor prognosis. Combination of radiotherapy and immunotherapy seems to be a promising approach for treating ESCC.
Mengjie Jiang   +4 more
doaj   +3 more sources

Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series

open access: yesOpen Life Sciences, 2023
Radiotherapy is an essential postoperative treatment for grade II gliomas. However, comparative dosimetric studies of different radiotherapy plans for grade II gliomas are still lacking.
Sun Mao   +4 more
doaj   +2 more sources

Mesenchymal Stem Cells for Mitigating Radiotherapy Side Effects

open access: yesCells, 2021
Radiation therapy for cancers also damages healthy cells and causes side effects. Depending on the dosage and exposure region, radiotherapy may induce severe and irreversible injuries to various tissues or organs, especially the skin, intestine, brain ...
Kai-Xuan Wang   +6 more
doaj   +2 more sources

Recent advances in radiotherapy and its associated side effects in cancer—a review

open access: yesJournal of Basic and Applied Zoology, 2019
Background Radiotherapy (RT) is the chief nonsurgical method to control malignant tumors. RT has advanced in both methodological and biological aspects over the past few decades.
Gomathi Mohan   +5 more
doaj   +2 more sources

Covid-19's impact on radiotherapy in the Republic of Srpska [PDF]

open access: yesVojnosanitetski Pregled, 2022
Background/Aim. Coronavirus disease 2019 (COVID-19) significantly affects patients with any type of chronic disease, especially the ones with neoplasm. The aim of this study was to investigate the impact of the COVID-19 pandemic on the weekly number of ...
Kolarević Goran   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy